2026 Another Catalyst Rich Year: AstraZeneca CFO

By BloombergApr 29, 2026, 6:16 PM

Aradhana Sarin, AstraZeneca CFO, joins Dani Burger and Katie Greifeld on "Bloomberg Deals." AstraZeneca's profit grew more than expected in the first quarter, bolstered by demand for its blockbuster cancer medicines.

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks Browse all ASX ETFs Explore Australia companies Find the right ASX index

2026 Another Catalyst Rich Year: AstraZeneca CFO

More from Australia

Avada loses CEO under 6-month notice

Forrestania Resources secures deal for 750,000 tonnes of ore

Lendlease terminates $90M Milan development sale

Beetaloo Energy secures licence covering 1,739 petajoules

Otto Energy to sell oil asset for US$6M

DUG Technology wins US$33.7M computing award

More ways to discover